Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancer.

[1]  C. Boni,et al.  Fluorouracil-alone versus high-dose folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research (GOIRC). , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  F. Pannuti,et al.  Randomized clinical trial with a weekly regimen of 5-FU vs 5-FU + intermediate-dose folinic acid in the treatment of advanced colo-rectal cancer. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  S. Barni,et al.  Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer). , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  M. Heim,et al.  Prospective Multicenter Phase-Ill Trial of Doxifluridine (5’dFUR) versus 5-Fluorouracil in Patients with Advanced Colorectal Carcinoma , 1991 .

[5]  J. Grem.  Current treatment approaches in colorectal cancer. , 1991, Seminars in oncology.

[6]  F. Calabresi,et al.  Doxifluridine in advanced colorectal cancer , 1991, Journal of surgical oncology. Supplement.

[7]  R. Herrmann.  Biochemical modulation of 5-fluorouracil. , 1990, Cancer treatment reviews.

[8]  Michael R. Green,et al.  The Modulation of Fluorouracil With Leucovorin in Metastatic Colorectal Carcinoma A Prospective Randomized Phase III Trial , 1990 .

[9]  S. Wadler,et al.  Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  G. Decoster,et al.  Phase I-II trial of doxifluridine (5'DFUR) administered as long-term continuous infusion using a portable infusion pump for advanced colorectal cancer. , 1989, European journal of cancer & clinical oncology.

[11]  J. Laurie,et al.  Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Hannigan,et al.  Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  N. Petrelli,et al.  The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  G. Decoster,et al.  Phase I study of oral doxifluridine using two schedules. , 1989, European journal of cancer & clinical oncology.

[15]  J G Fryer,et al.  A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  C. Erlichman,et al.  A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  F. Cavalli,et al.  A randomized comparison of doxifluridine and fluorouracil in colorectal carcinoma. , 1988, European journal of cancer & clinical oncology.

[18]  Hryniuk Wm.  The importance of dose intensity in the outcome of chemotherapy. , 1988 .

[19]  A. Rubagotti,et al.  A randomized trial of 5-fluorouracil alone versus 5-fluorouracil and high dose leucovorin in untreated advanced colorectal cancer patients. , 1988, Advances in experimental medicine and biology.

[20]  N. Petrelli,et al.  A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  S. Schraub,et al.  Phase II clinical evaluation of doxifluridine. , 1986, Cancer treatment reports.

[22]  J. Fourtillan,et al.  Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  F. Cavalli,et al.  Phase II study of doxifluridine in advanced colorectal adenocarcinoma. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  R. Diasio,et al.  Metabolism and biological activity of 5'-deoxy-5-fluorouridine, a novel fluoropyrimidine. , 1980, Cancer research.

[25]  W. Bollag,et al.  Tumor inhibitory effects of a new fluorouracil derivative: 5'-deoxy-5-fluorouridine. , 1980, European journal of cancer.

[26]  A. Cook,et al.  Fluorinated pyrimidine nucleosides. 3. Synthesis and antitumor activity of a series of 5'-deoxy-5-fluoropyrimidine nucleosides. , 1979, Journal of medicinal chemistry.

[27]  G. Ramírez,et al.  A phase III study comparing the clinical utility of four regimens of 5‐Fluorouracil. A preliminary report , 1977, Cancer.

[28]  C. Moertel.  Chemotherapy of gastrointestinal cancer. , 1978, The New England journal of medicine.

[29]  C. Heidelberger,et al.  Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory Compounds , 1957, Nature.